key: cord-0780241-6cm2xy89
authors: Ward, R. Parker; Lee, Linda; Ward, Timothy J.; Lang, Roberto M.
title: Utilization and Appropriateness of Transthoracic Echocardiography In Response to the COVID-19 Pandemic
date: 2020-04-10
journal: J Am Soc Echocardiogr
DOI: 10.1016/j.echo.2020.04.006
sha: 14528091862e3e3f55066f838521c0f99f23d90d
doc_id: 780241
cord_uid: 6cm2xy89

nan

In response to the coronavirus disease 2019 (COVID-19) pandemic, the delivery of medical services has been fundamentally altered. Transthoracic Echocardiography (TTE) plays a prominent role in identifying cardiac complications of COVID-19, but TTE imaging places sonographers within two feet of patients' faces, well within the droplet zone, for at least 20 minutes. Consequently, cardiac sonographers have among the highest exposures to COVID-19 among healthcare providers, and consume scarce personal protective equipment (PPE) with each exam. We sought to investigate the impact of the COVID-19 pandemic on the utilization and appropriateness of TTE in a busy academic medical center in an urban endemic area.

We reviewed adult TTE utilization at the University of Chicago Medicine (UCM) from January 19 th , 2020, the week of the first reported case of COVID-19 in the state of Illinois (2 nd in the There were 3642 total TTEs performed in the 2.5-month study period, including 1983 (55%) inpatient and 1659 (45%) outpatient TTEs. Of all these studies, 13% were L-TTE, including 17% of inpatient and 4% of outpatient TTEs. Among the 3275 (90%) TTEs for which AUC designation could be determined, 88% were "appropriate" and 6% were "rarely appropriate".

Compared to the weeks prior, the PROTOCOL resulted in a 66% decline of the overall weekly TTE volume, including 48% among inpatient and 84% among outpatient studies. (Figure 1) The percentage of L-TTE significantly increased after the PROTOCOL among all TTEs (12% vs. 28%, p<0.001), and more than doubled among inpatient TTEs (15% vs. 34%, p<0.001). The rate of "appropriate" TTEs significantly increased (87% vs. 96%, p<0.001) after the PROTOCOL, while "rarely appropriate" TTEs were almost completely eliminated (7% vs. 1%, p<0.001).

These findings illustrate the impact of the early stages of the COVID-19 pandemic on the practice of TTE in an academic medical center in an urban COVID-19 "hot spot". Response to the pandemic requires striving for the optimal balance between best patient care and the safety of providers. This is particularly challenging for TTE practice, given its core role in the diagnosis of cardiac complications of COVID-19, and the uniquely high exposure risk for sonographers performing TTE. In addition, hospital and State COVID-19 pandemic mandates have required fundamental alterations in TTE practice. At our institution, these factors necessarily required a new workflow involving physician review of all echocardiography referrals. This focused intervention resulted in a marked decrease in TTE volume, and significant improvements in the appropriateness of the TTEs performed. The rate of "rarely appropriate" TTEs performed in our laboratory is found to be at the low end of the published experience, but nonetheless a "physician level review" of echo orders essentially eliminated "rarely appropriate" TTEs. (3) (4) (5) While the context of a pandemic may limit applicability, this finding is relevant in light of the recent Center for Medicare and Medicaid Services mandate requiring AUC determinations for "advanced" imaging modalities. Echocardiography is not subject to this mandate, but our findings support the conclusion that more scrutiny at the point of order is beneficial. (6) L-TTE utilization as a percentage of all TTEs has also markedly increased during the pandemic.

The primary cardiac complications of COVID-19 involve myocardial injury with troponin elevations, including myocarditis and acute coronary syndromes. (7) Thus left ventricular performance is of primary importance, and can be effectively evaluated with Limited 2-D TTE.

(5) L-TTE also reduces sonographer imaging time and thus minimizes this high-risk exposure.

Cardiac Point-of-Care Ultrasound (POCUS) offers similar benefits, and may allow rapid focused diagnostic assessment by providers already at the bedside. (8) However, the lack of uniform formal reporting and image storage for later review may be limiting.

In summary, the practice of TTE has acutely adapted to the COVID-19 pandemic. Our findings suggest that a strategy of more active physician review and increased use of Limited TTE can eliminate unnecessary TTEs, reduce consumption of PPE, and minimize high-risk sonographer exposure to the virus. 

American College of Cardiology Foundation Appropriate Use Criteria Task F, American Society of E, American Heart A, American Society of Nuclear C, Heart Failure Society of A

Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance American College of Chest Physicians

Appropriate use criteria in echocardiography: an observational institutional study with the perspective of a quality improvement project

Temporal changes in appropriateness of cardiac imaging

Association Between Offering Limited Left Ventricular Ejection Fraction Echocardiograms and Overall Use of Echocardiography

Potential Effects of Coronaviruses on the Cardiovascular System

Recommendations for Echocardiography Laboratories Participating in Cardiac Point of Care Cardiac Ultrasound (POCUS) and Critical Care Echocardiography Training: Report from the American Society of Echocardiography